PerfuseCell Cronus A/S: Financial statements 2025
CVR: 31606810
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PerfuseCell Cronus A/S (CVR 31606810) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836. The solvency ratio was 46.9%.
- Gross Profit
- DKK 20,467
- Profit/Loss
- DKK 23,973
- Equity
- DKK 1,070,836
- Total Assets
- DKK 2,282,693
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 20 t. | 24 t. | 1.1 mio. | - |
| 2024 | 625 t. | -15 | 2 t. | 1 mio. | - |
| 2023 | 711 t. | 150 t. | 171 t. | 1 mio. | - |
| 2022 | 550 t. | 131 t. | 89 t. | 873 t. | - |
| 2021 | 150 t. | 34 t. | 34 t. | 784 t. | - |
Official annual report
How creditworthy is PerfuseCell Cronus A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of April 11, 2025, Per Stobbe is registered as adm. dir. of PerfuseCell Cronus A/S.
As of April 11, 2025, Flemming Petersen has stepped down as director of PerfuseCell Cronus A/S.
PerfuseCell Cronus A/S has published its annual report for 2024. Revenue came to DKK 625,171, and the net result was DKK 2,216.
About PerfuseCell Cronus A/S
PerfuseCell Cronus A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 2008. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named PerfuseCell A/S and PumpCell A/S. The management consists of Per Stobbe. The board consists of August Kisling Stobbe, Flemming Petersen and Per Stobbe. The company is owned by Stobbe GmbH. In 2025, the company reported a gross profit of DKK 20,467 and a net result of DKK 23,973 compared with DKK 2,216 the year before. Equity in the 2025 report amounted to DKK 1,070,836.